Dr. Randah Al Kana, MD is a hematology specialist in Freehold, NJ and has been practicing for 26 years. She graduated from Damascus Univ in 1984 and specializes in hematology and hematopathology.
Insurance Check
Search for your insurance provider
Dr. Al Kana accepts
Accepted insurance can change. Please double-check when making an appointment.
Dr. Al Kana accepts the following insurance:
- Anthem
- Pathway X Ind PPO Direct Access CT
- Blue Cross Blue Shield
- Blue Card PPO
- Capital Blue Cross
- Empire Blue Cross Blue Shield
- Empire Blue Cross Blue Shield HMO
- First Health (Coventry Health Care)
- First Health (Coventry Health Care) PPO
- QualCare
- QualCare HMO
- QualCare PPO
Background Check
No malpractice claims found for New Jersey
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Dr. Al Kana's Top Procedures and Conditions
Treatment Frequency
Cancer
normal
normal
Treatment Frequency
Dr. Al Kana treats Cancer more than 26% of her peers
Dr. Al Kana treats this condition more than 26% of her peers
Rating Includes other areas of care:
- Adenoid Cystic Carcinoma
- Adolescent Cancer
- Adrenal Cortical Carcinoma
- Adrenal Gland Cancer
- Adult Cerebral Astrocytoma
- Adult Small Cell Lung Cancer
- Ampullary Carcinoma
- Anal and Rectal Cancer
- Anal Cancer
- Anaplastic Oligodendroglioma
- Angiosarcoma of the Breast
- Appendix Cancer
- Astrocytoma
- Basal Cell Carcinoma (BCC)
- Basal Type Breast Cancer
- Benign Astrocytoma
- Bile Duct Cancer
- Biliary Cancer
- Bladder Cancer
- Blood Cancer
- Bone Cancer
- Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- Brainstem Glioma
- Breast Cancer
- Breast Cancer Recurrence
- Bronchioalveolar Carcinoma
- Bronchogenic Carcinoma
- Cancer of Floor of Mouth
- Cerebellar Astrocytoma
- Cerebral Astrocytoma
- Cervical Cancer
- Cholangiocarcinoma
- Chordoma
- Choriocarcinoma
- Chromophobe Renal Cell Carcinoma
- Clear Cell Adenocarcinoma
- Clear Cell Renal Cell Carcinoma
- Colorectal Cancer
- Cutaneous Squamous Cell Carcinoma
- Distal Colorectal Cancer
- Distal Gastrointestinal Tract Cancers
- Ductal Carcinoma in Situ
- Duodenal Cancer
- Ear Cancer
- Endocrine Cancer
- Endometrial Cancer
- ENT Cancer
- Epidermoid Carcinoma
- Epithelial-Myoepithelial Carcinoma
- Esophageal Cancer
- Extrahepatic Bile Duct Cancer
- Eye Cancer
- Facial Skin Cancer
- Fallopian Tube Cancer
- Familial Colorectal Cancer
- Familial Pancreatic Cancer
- Familial Renal Cancer
- Familial Renal Cell Carcinoma
- Fibrolamellar Hepatocellular Carcinoma
- Follicular Adenocarcinoma
- Follicular Thyroid Cancer
- Gall Bladder Cancer
- Gallbladder & Biliary Tract Cancer
- Gastric Cancer, Borrmann 4
- Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
- Genital System Cancer
- Genitourinary Cancers
- Gland Cancer
- Glassy Cell Carcinoma
- Glioma
- Gliomatosis Cerebri
- Gynecologic Cancer
- Hamartomatous Colorectal Cancer
- Heart Cancer
- Hepatobiliary Cancer
- Hepatocellular Cancer
- Hepatocellular Carcinoma
- Hip Cancer
- Hypopharyngeal Cancer
- Inflammatory Breast Cancer
- Infundibulocystic Basal Cell Carcinoma
- Intestinal Cancer
- Intrahepatic Cholangiocarcinoma
- Invasive Breast Cancer
- Invasive Ductal Carcinoma
- Invasive Lobular Carcinoma
- Joint Cancer
- Juvenile Pilocytic Astrocytoma
- Laryngeal Cancer
- Laryngeal Carcinoma
- Limb Cancer
- Lip Cancer
- Liver Cancer
- Locally Advanced Breast Cancer
- Lung Cancer
- Lymphoma of the Breast
- Male Breast Cancer
- Male Genitourinary Cancer
- Malignant Astrocytoma
- Malignant Breast Tumor
- Malignant Glioma
- Mediastinal Cancer
- Medullary Thyroid Cancer
- Medulloblastoma
- Melanoma-Astrocytoma Syndrome
- Merkel Cell Cancer
- Metastatic Adrenal Gland Cancer
- Metastatic Blood Cancer
- Metastatic Bone Cancer
- Metastatic Breast Cancer
- Metastatic Cancer
- Metastatic Liver Cancer
- Metastatic Lymph Cancer
- Metastatic Nervous System Cancer
- Metastatic Prostate Cancer
- Metastatic Skin Cancer
- Metastatic Soft Tissue Cancer
- Metastatic Spinal Cord Cancer
- Metastatic Squamous Neck Cancer With Occult Primary
- MSI-H Colorectal Cancer
- MSI-L Colorectal Cancer
- MSS Colorectal Cancer
- Muscle Cancer
- Nasal Cavity Cancer
- Nasopharyngeal Cancer
- Neck Cancer
- Nerve Cancer
- Neuroendocrine Cancer
- Nevoid Basal Cell Carcinoma Syndrome
- Nodular Basal Cell Carcinoma
- Noduloulcerative Basal Cell Carcinoma
- Non-Melanoma Skin Cancer
- Nonpolyposis Colorectal Cancer, Familial
- Non-Small Cell Lung Cancer
- Nose Cancer
- Oligodendroglioma
- Oral Cancer
- Oral Squamous Cell Carcinoma
- Oropharyngeal Cancer
- Oropharyngeal Cancer, Adult
- Osteosarcoma of the Breast
- Ovarian Cancer
- Ovarian Epithelial Cancer
- Palate Cancer
- Pancreatic Cancer
- Pancreatic Islet Cell Cancer
- Papillary Renal Cell Carcinoma
- Papillary Thyroid Cancer
- Paranasal Sinus Cancer
- Parathyroid (Gland) Cancer
- Parathyroid Carcinoma
- Parotid Gland Cancer
- Pediatric Cancer
- Pelvic Cancer
- Penile Cancer
- Pharyngeal Cancer
- Pigmented Basal Cell Carcinoma
- Pleura Cancer
- Pre-Invasive Breast Cancer
- Primary Prostate Cancer
- Prostate Cancer
- Prostate Cancer - Hereditary - 1
- Prostate Cancer - Hereditary - 10
- Prostate Cancer - Hereditary - 11
- Prostate Cancer - Hereditary - 14
- Prostate Cancer - Hereditary - 2
- Prostate Cancer - Hereditary - 3
- Prostate Cancer - Hereditary - 4
- Prostate Cancer - Hereditary - 5
- Prostate Cancer - Hereditary - 6
- Prostate Cancer - Hereditary - 7
- Prostate Cancer - Hereditary - 8
- Prostate Cancer - Hereditary - 9
- Prostate Cancer - Hereditary - X-Linked 1
- Prostate Cancer - Hereditary - X-Linked 2
- Prostate Cancer - Hereditary -12
- Prostate Cancer - Hereditary -13
- Prostate Cancer - Hereditary -15
- Radiation-Induced Angiosarcoma of the Breast
- Rectal Cancer
- Renal (Kidney) Cancer
- Renal Cell Cancer
- Respiratory System Cancer
- Retinal Cancer
- Salivary Gland Cancer
- Sebaceous Gland Carcinoma
- Secretory Breast Carcinoma
- Sinonasal Undifferentiated Carcinoma
- Sinus Cancer
- Skin Cancer
- Small Cell Lung Cancer
- Spinal Cord Cancer
- Spleen Cancer
- Sporadic Colorectal Cancer
- Squamous Cell Carcinoma
- Squamous Cell Carcinoma of Conjunctiva
- Squamous Cell Carcinoma of Head and Neck
- Stomach and Small Intestine Cancer
- Stomach Cancer
- Stomach Cancer, Familial
- Superficial Basal Cell Carcinoma
- Supraglottic Laryngeal Cancer
- Testicular Cancer
- Thoracic Cancer
- Throat Cancer
- Thymus Cancer
- Thyroid Cancer
- Thyroid Cancer, Anaplastic
- Thyroid Cancer, Familial Medullary
- Thyroid Cancer, Hurthle Cell
- Tongue Cancer
- Trachea Cancer
- Transitional Cell Cancer
- Transitional Cell Carcinoma
- Tubular Carcinoma
- Urachal Cancer
- Ureteral Cancer
- Urinary Tract Cancer
- Uterine Cancer
- Vaginal Cancer
- Visual Pathway and Hypothalamic Glioma
- Vocal Cord Carcinoma
- Vulvar Cancer
Blood Disorders
normal
normal
Treatment Frequency
Dr. Al Kana treats Blood Disorders more than 3% of her peers
Dr. Al Kana treats this condition more than 3% of her peers
Dr. Al Kana's conditions and procedures:
- Acute Leukemia
- Acute Myeloid Leukemia
- All Lymphoma
- Anemia
- Bleeding Disorders
- Blood Disorders
- Bone Disorders
- Cancer
- Central Nervous System Lymphoma
- Chronic Lymphocytic Leukemia
- Lymphocytosis
- Lymphoma, Large-Cell
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Non-Hodgkin's Lymphoma
- Pancytopenia
- Primary Central Nervous System Lymphoma
- Reticulosarcoma
- Vascular Disease
Dr. Al Kana's Reviews
Be the first to leave a review
How likely are you to recommendDr. Al Kana?
Overall Patient Satisfaction
About Me
Biography
Dr. Randah Al Kana, MD is a hematology specialist in Freehold, NJ and has been practicing for 26 years. She graduated from Damascus Univ in 1984 and specializes in hematology and hematopathology.
Specialties
- Hematology
- Hematopathology
Board Certifications
- Anatomic & Clinical Pathology
- Hematology & Pathology
Education
Awards
- Healthgrades Honor Roll
Compare Providers
More providers who are similar to Dr. Al Kana
